Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?

INTRODUCTION: Cost-effectiveness analysis (CEA) using country-specific thresholds tied to gross domestic product (GDP) might not be appropriate in countries with low healthcare investment and a high disease burden as a consequence. METHODS: Using data from previously published CEA of rotavirus vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Standaert, Baudouin, Ethgen, Olivier, Emerson, Rachel, Postma, Maarten, Mauskopf, Josephine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209096/
https://www.ncbi.nlm.nih.gov/pubmed/25331617
http://dx.doi.org/10.1007/s12325-014-0160-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209096/
https://www.ncbi.nlm.nih.gov/pubmed/25331617
http://dx.doi.org/10.1007/s12325-014-0160-6

Ejemplares similares